Oppenheimer & Co. Inc. Has $3.99 Million Position in UiPath Inc. (NYSE:PATH)

Oppenheimer & Co. Inc. boosted its position in shares of UiPath Inc. (NYSE:PATH - Free Report) by 60.6% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 314,247 shares of the company's stock after purchasing an additional 118,606 shares during the period. Oppenheimer & Co. Inc. owned about 0.06% of UiPath worth $3,994,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in PATH. Jacobs Levy Equity Management Inc. lifted its holdings in UiPath by 554.8% during the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 4,026,502 shares of the company's stock valued at $51,539,000 after purchasing an additional 3,411,562 shares during the last quarter. Senvest Management LLC lifted its holdings in UiPath by 16.7% during the 3rd quarter. Senvest Management LLC now owns 10,894,483 shares of the company's stock valued at $139,449,000 after purchasing an additional 1,559,500 shares during the last quarter. Worldquant Millennium Advisors LLC bought a new position in UiPath during the 3rd quarter valued at about $19,071,000. Geode Capital Management LLC raised its stake in shares of UiPath by 7.2% in the third quarter. Geode Capital Management LLC now owns 7,312,068 shares of the company's stock worth $93,619,000 after acquiring an additional 493,502 shares during the last quarter. Finally, Washington Harbour Partners LP bought a new position in shares of UiPath in the third quarter worth about $5,684,000. 62.50% of the stock is owned by institutional investors.

UiPath Price Performance

Shares of UiPath stock traded up $0.28 on Wednesday, hitting $12.07. The company had a trading volume of 7,909,771 shares, compared to its average volume of 9,306,616. The stock has a 50-day moving average of $13.55 and a 200-day moving average of $13.19. The firm has a market capitalization of $6.63 billion, a P/E ratio of -75.41 and a beta of 0.98. UiPath Inc. has a twelve month low of $10.37 and a twelve month high of $25.47.

Remove Ads

Insider Transactions at UiPath

In other UiPath news, CFO Ashim Gupta sold 47,227 shares of the company's stock in a transaction on Friday, January 3rd. The shares were sold at an average price of $13.06, for a total transaction of $616,784.62. Following the sale, the chief financial officer now directly owns 856,538 shares of the company's stock, valued at approximately $11,186,386.28. This represents a 5.23 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CAO Hitesh Ramani sold 25,000 shares of the company's stock in a transaction on Friday, January 3rd. The stock was sold at an average price of $13.05, for a total transaction of $326,250.00. Following the sale, the chief accounting officer now directly owns 269,421 shares in the company, valued at $3,515,944.05. This trade represents a 8.49 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 22.37% of the stock is currently owned by insiders.

Analyst Ratings Changes

PATH has been the subject of a number of research analyst reports. UBS Group initiated coverage on shares of UiPath in a research note on Thursday, December 12th. They issued a "sell" rating and a $14.00 target price for the company. BMO Capital Markets boosted their target price on shares of UiPath from $15.00 to $16.00 and gave the stock a "market perform" rating in a research note on Friday, December 6th. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $16.00 target price on shares of UiPath in a research note on Friday, December 6th. Needham & Company LLC reaffirmed a "hold" rating on shares of UiPath in a research note on Wednesday, January 15th. Finally, Barclays dropped their target price on shares of UiPath from $16.00 to $15.00 and set an "equal weight" rating for the company in a research note on Friday, January 10th. One investment analyst has rated the stock with a sell rating, sixteen have assigned a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $17.44.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.